For the past 25 years, Chromadex has been at the forefront of innovation and research in healthy aging. Rob Fried, the company's CEO, reflects on its evolution from an analytical testing service to a developer of proprietary ingredients, with a particular focus on NAD precursors like nicotinamide riboside (NR).